Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Nat Med
; 28(5): 1095-1096, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35449420
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2022
Type:
Article
Affiliation country:
United States